baclofen 5mg/5ml oral solution
syri pharma limited t/a thame laboratories - baclofen - oral solution - 5 mg/5ml - other centrally acting agents; baclofen
levetiracetam- levetiracetam tablet, extended release
torrent pharmaceuticals limited - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 500 mg - levetiracetam extended-release tablets are indicated as adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age and older with epilepsy. levetiracetam extended-release tablets are contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions (5.4)]. levetiracetam extended-release tablets levels may decrease during pregnancy [see warnings and precautions (5.9) ] pregnancy category c there are no adequate and well-controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam extended-release tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. oral administration of levetiracetam to female rats throughout pregnancy and lactation led to increased incidences of minor fetal ske
baclofen thame 10mg/5ml oral solution
syri pharma limited floor 0 1 wml, 1 windmill lane dublin 2, d02 f206, ireland - baclofen - oral solution - baclofen 10 mg/5ml - muscle relaxants
idaman pharma chlorpromazine tablet 25mg
idaman pharma manufacturing sdn bhd - chlorpromazine hydrochloride -
gabin 100 milligram capsules hard
aurobindo pharma limited - gabapentin - capsules hard - 100 milligram - other antiepileptics
gabin 300 milligram capsules hard
aurobindo pharma limited - gabapentin - capsules hard - 300 milligram - other antiepileptics
gabin 400 milligram capsules hard
aurobindo pharma limited - gabapentin - capsules hard - 400 milligram - other antiepileptics
anbesol anaesthetic antiseptic oromucosal solution
alliance pharma (ireland) limited - lidocaine hydrochloride; chlorocresol; cetylpyridinium chloride - oromucosal solution - . - amides; lidocaine, combinations
dicycloverine hydrochloride 10mg/5ml oral solution
syri pharma limited t/a thame laboratories - dicycloverine hydrochloride - oral solution - 10 mg/5ml - synthetic anticholinergics, esters with tertiary amino group; dicycloverine
baclofen (noumed)
noumed pharmaceuticals limited - baclofen 10mg - tablet - 10 mg - active: baclofen 10mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose povidone - " spasticity of the skeletal muscles in multiple sclerosis. " spastic conditions occurring in spinal-cord diseases of infectious, degenerative, traumatic, neoplastic, or unknown origin: e.g. spastic spinal paralysis, amyotrophic lateral sclerosis, syringomyelia, transverse myelitis, traumatic paraplegia or paraparesis, and compression of the spinal cord; muscle spasm of cerebral origin, especially where due to infantile cerebral palsy, as well as following cerebrovascular accidents or in the presence of neoplastic or degenerative brain disease.